Breast Cancer
News
Fulvestrant bests anastrozole in advanced breast cancer
Key clinical point: The selective estrogen receptor down-regulator fulvestrant proved superior to anastrozole in disease progression and overall...
Original Report
Predictors of resolution in navigated patients with abnormal cancer screening tests
Original Report
Information and communication needs of Chinese American breast cancer patients: perspectives on survivorship care planning
News
Genetic test predicts 10-year risk of DCIS recurrence
Key clinical point: A genetic assay can accurately predict the 10-year risk of local recurrence in women with ductal carcinoma in situ. Major...
News
Acupuncture beats gabapentin for hot flashes in RCT
Key clinical point: Breast cancer survivors with frequent hot flashes obtained more benefit from 8 weeks of electroacupuncture than gabapentin.
News
AI-induced symptoms don’t predict survival
Key clinical point: Vasomotor and musculoskeletal symptoms induced by aromatase inhibitors do not signal a more-intense treatment response or...
Video
VIDEO: What have we learned about prevention of breast cancer from IBIS-1?
News
20 years after initiating preventive tamoxifen, less breast cancer but no survival benefit
Key clinical point: Prophylactic tamoxifen reduced breast cancers in vulnerable women, compared with placebo, but didn’t affect overall mortality...
Video
VIDEO: What was the most interesting thing you learned at the meeting?
Video
VIDEO: Dr. Prudence Francis describes how SOFT results will change practice
News
SOFT trial endorses selective ovarian suppression in early breast cancer
Key clinical point: Ovarian function suppression plus adjuvant exemestane is the best therapy for women with hormone receptor–positive early...